Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousal
- 31 December 2000
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 55 (6) , 494-501
- https://doi.org/10.1054/mehy.2000.1100
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Anandamide‐induced mobilization of cytosolic Ca2+ in endothelial cellsBritish Journal of Pharmacology, 1999
- Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological FunctionBiochemical and Biophysical Research Communications, 1999
- Involvement of CB1cannabinoid receptors in the EDHF-dependent vasorelaxation in rabbitsBritish Journal of Pharmacology, 1999
- Psychosis and Cannabis Abuse in the GambiaThe British Journal of Psychiatry, 1993
- Mortality and Causes of Death in First Admitted Schizophrenic PatientsThe British Journal of Psychiatry, 1993
- Effect of synthetic enantiomeric cannabinoids on platelet aggregationCanadian Journal of Physiology and Pharmacology, 1992
- Neuroleptic effects on platelet aggregation: a study in normal volunteers and schizophrenicsPsychological Medicine, 1987
- Sex Differences in Physiological Responses to Stress and in Coronary Heart Disease: A Causal Link?Psychophysiology, 1987
- Effects of Δ9-tetrahydrocannabinol and cannabidiol on phospholipase and other enzymes regulating arachidonate metabolismProstaglandins and Medicine, 1980
- Severe Shock Caused by Chlorpromazine HypersensitivityThe British Journal of Psychiatry, 1973